User profiles for P. Tarsia

Paolo Tarsia

MD, Niguarda, Policlinico
Verified email at ospedaleniguarda.it
Cited by 5827

Understanding the burden of pneumococcal disease in adults

…, M Mantero, PA Santus, P Tarsia - Clinical Microbiology and …, 2012 - Wiley Online Library
… placebo group 80/504 (15.9%), p 0.4), notwithstanding pneumonia accounted for 32.5%
of deaths in the control group. The results of the above-reported meta-analyses have been …

[HTML][HTML] Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment

…, R Danesi, A Vanzulli, F Sandomenico, P Tarsia… - ESMO open, 2022 - Elsevier
Background Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease
resulting from exposure to drugs causing inflammation and possibly interstitial fibrosis. …

[HTML][HTML] Chlamydophila pneumoniae

F Blasi, P Tarsia, S Aliberti - Clinical Microbiology and Infection, 2009 - Elsevier
Chlamydophila pneumoniae infection is ubiquitous. It accounts for 10% of community-acquired
pneumonias and 5% of cases of pharyngitis, bronchitis and sinusitis in both …

Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing

…, L Fagetti, R Droghetti, P Tarsia… - European …, 2000 - Eur Respiratory Soc
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in
reactive airway disease, 71 children aged 2-14 yrs with an acute episode of wheezing and 80 …

Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia

…, AM Brambilla, S Seghezzi, P Tarsia… - Clinical infectious …, 2012 - academic.oup.com
… All tests were 2-tailed, and a P value <.05 was considered statistically significant. … CI,
25%–50%) in those with a score of ≥3 (P < .001). Figure 2 depicts the ROC curve for the score. The …

Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial

…, A Maffei, R Martinotti, P Tarsia, V Monzani, P Pelosi - Chest, 2010 - Elsevier
… Patients randomized to CPAP reached the end point in a median of 1.5 h, whereas controls
reached the end point in 48 h (P < .001). The proportion of patients who reached the primary …

Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia

…, F Corradi, P Pelosi, A Bignamini, P Tarsia… - Intensive care …, 2014 - Springer
… The CPAP group showed a faster and greater improvement in oxygenation in comparison
to controls (p < 0.001). In either study group, no relevant adverse events were detected. …

Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment

F Blasi, S Damato, R Cosentini, P Tarsia, R Raccanelli… - Thorax, 2002 - thorax.bmj.com
Background: A study was undertaken to evaluate Chlamydia pneumoniae chronic infection,
other respiratory infections, and functional impairment in patients with chronic bronchitis (…

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis

…, F Colombo, M Moreno, S Pastori, CF Perno, P Tarsia… - Journal of Infection, 2020 - Elsevier
… The respiratory function was heavily impaired as described by a median P/F value of 180
mmHg (IQR 96–259). The majority (69.8%) exhibited a critical clinical picture as defined …

Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective

…, JD Chalmers, AM Zanaboni, R Cosentini, P Tarsia… - Thorax, 2013 - thorax.bmj.com
… was MRSA, followed by MDR P aeruginosa and ESBL+ pathogens. Characteristics and
outcomes of patients whose pneumonia was due to P aeruginosa and MRSA are reported in the …